Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

Similar articles for PubMed (Select 8543541)

1.

The use and tolerability of fluoxetine in geropsychiatric inpatients.

Orengo CA, Kunik ME, Molinari V, Workman RH.

J Clin Psychiatry. 1996 Jan;57(1):12-6.

PMID:
8543541
2.

Modeling trajectory of depressive symptoms among psychiatric inpatients: a latent growth curve approach.

Clapp JD, Grubaugh AL, Allen JG, Mahoney J, Oldham JM, Fowler JC, Ellis T, Elhai JD, Frueh BC.

J Clin Psychiatry. 2013 May;74(5):492-9. doi: 10.4088/JCP.12m07842.

3.

Serum sodium changes in fluoxetine users at different age groups.

Shakibaei F, Gholamrezaei A, Alikhani M, Talaeizadeh K.

Iran J Psychiatry. 2010 Summer;5(3):113-6.

4.

Use of dolls as a therapeutic intervention: relationship to previous negative behaviors and pro re nata (prn) Haldol use among geropsychiatric inpatients.

Green L, Matos P, Murillo I, Neushotz L, Popeo D, Aloysi A, Samuel J, Craig E, Porter C, Fitzpatrick JJ.

Arch Psychiatr Nurs. 2011 Oct;25(5):388-9. doi: 10.1016/j.apnu.2011.05.003. Epub 2011 Jul 12.

PMID:
21978807
5.

Effect of fluoxetine on some cognitive functions of patients of depression.

Jaykaran, Bhardwaj P, Kantharia ND, Yadav P, Panwar A.

Indian J Psychol Med. 2009 Jan;31(1):24-9. doi: 10.4103/0253-7176.53311.

6.

CDI Scores in Pediatric Psychiatric Inpatients: A Brief Retrospective Static Group Comparison.

Friedberg RD, Sinderman SA.

Depress Res Treat. 2011;2011:134179. doi: 10.1155/2011/134179. Epub 2011 Jun 30.

7.

A naturalistic study of trazodone in the treatment of behavioral complications of dementia.

Houlihan DJ, Mulsant BH, Sweet RA, Rifai AH, Pasternak R, Rosen J, Zubenko GS.

Am J Geriatr Psychiatry. 1994 Winter;2(1):78-85.

PMID:
21629010
8.

Aggression and psychopharmacological treatments in major psychosis and personality disorders during hospitalisation.

Mauri MC, Rovera C, Paletta S, De Gaspari IF, Maffini M, Altamura AC.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1631-5. doi: 10.1016/j.pnpbp.2011.05.008. Epub 2011 May 17.

PMID:
21620921
9.

Prevalence and influence of psychiatric comorbidity on rehabilitation outcome for older hospital inpatients.

Gluyas C, Lum C, Chong SY, Borg C, Haines TP.

Int Psychogeriatr. 2011 Nov;23(9):1502-14. doi: 10.1017/S1041610211000731. Epub 2011 May 4.

PMID:
21554793
10.

Fluoxetine in the elderly.

Thorpe LU.

Can Fam Physician. 1989 Oct;35:1991. No abstract available.

11.

Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial.

Zhang WJ, Yang XB, Zhong BL.

J Altern Complement Med. 2009 Aug;15(8):837-44. doi: 10.1089/acm.2008.0607.

PMID:
19678773
12.

Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder.

Coskun M, Zoroglu S.

J Child Adolesc Psychopharmacol. 2009 Jun;19(3):297-300. doi: 10.1089/cap.2008.055.

PMID:
19519265
13.

Assessing depression outcome in patients with moderate dementia: sensitivity of the HoNOS65+ scale.

Canuto A, Rudhard-Thomazic V, Herrmann FR, Delaloye C, Giannakopoulos P, Weber K.

J Neurol Sci. 2009 Aug 15;283(1-2):69-72. doi: 10.1016/j.jns.2009.02.312. Epub 2009 Mar 3.

PMID:
19261298
14.

Reduction of suboptimal prescribing and clinical outcome for dementia patients in a senior behavioral health inpatient unit.

Chan VT, Woo BK, Sewell DD, Allen EC, Golshan S, Rice V, Minassian A, Daly JW.

Int Psychogeriatr. 2009 Feb;21(1):195-9. doi: 10.1017/S104161020800803X. Epub 2008 Nov 20.

PMID:
19019261
15.

A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.

Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.

Int Clin Psychopharmacol. 2008 Sep;23(5):269-75. doi: 10.1097/YIC.0b013e328301a74c.

PMID:
18703936
16.

Elders with first psychiatric hospitalization for depression.

Choi S, Rozario P, Morrow-Howell N, Proctor E.

Int J Geriatr Psychiatry. 2009 Jan;24(1):33-40. doi: 10.1002/gps.2064.

17.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.

PMID:
17909125
18.

Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.

Rainer M, Haushofer M, Pfolz H, Struhal C, Wick W.

Eur Psychiatry. 2007 Sep;22(6):395-403. Epub 2007 May 4.

PMID:
17482432
19.

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.

Depress Anxiety. 2008;25(1):46-54.

PMID:
17149753
20.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk